A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study

Documents similaires

• Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
  par: Muneto Tatsumoto, et autres
  Publié: (2024)
• Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
  par: Nathaniel M. Schuster, et autres
  Publié: (2025)
• Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
  par: Koichi Ikeda, et autres
  Publié: (2025)
• TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms
  par: Philip V. Reducha, et autres
  Publié: (2025)
• Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
  par: Shuu‐Jiun Wang, et autres
  Publié: (2024)